Tizanidine
- Product NDC
- 67296-1192
- 11-digit product format
- 672961192
- Labeler code
- 67296
- Product ID
- 67296-1192_b8d064ea-f375-569d-e053-2995a90ab730
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Tizanidine
- Dosage form
- TABLET
- Route
- ORAL
- Labeler
- RedPharm Drug, Inc.
- Application
- ANDA091283
- Marketing category
- ANDA
- Marketing start
- 2019-10-29
- Marketing end
- 0000-00-00
- Substance
- TIZANIDINE HYDROCHLORIDE
- Active strength
- 4 mg/1
- Pharmacologic classes
- Adrenergic alpha2-Agonists [MoA],Central alpha-2 Adrenergic Agonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Product Concepts#
FDA-Initiated Inactive NDC Indexing#
DailyMed Package Descriptions#
Package NDC, Product, Description table| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|
| 67296-1192-1 | Tizanidine | 15 in 1 BOTTLE | TABLET | 15 | | 12 |
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 67296-1192 | TIZANIDINE TABLET [REDPHARM DRUG, INC.] | 12 | Legacy NDC, 1 package rows | 20240716_9612d19b-9362-61ec-e053-2a95a90a04ce.zip |
DailyMed RxNorm Mappings#
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67296-1192-1 | 67296119201 | 15 TABLET in 1 BOTTLE (67296-1192-1) | 15 tablet | 2019-10-29 | 0000-00-00 | No | No | Current |